Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Net Loss Per Share - Schedule of Antidilutive Securities (Details)

v3.24.2
Note 15 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Antidilutive Securities (in shares) 2,321 3,056 2,321 3,056
Share-Based Payment Arrangement, Option [Member]        
Antidilutive Securities (in shares) 192 261 192 261
Restricted Stock [Member]        
Antidilutive Securities (in shares) 1,082 1,555 1,082 1,555
Warrant [Member]        
Antidilutive Securities (in shares) 1,047 1,240 1,047 1,240